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ABSTRACT 
 Since caloric restriction (CR) can modify multiple pathways central to the 
ischemic cascade and enhance neuroplasticity mechanisms, we hypothesized that CR 
should exert protective effects following brain ischemia.  Previous studies have suggested 
benefit when CR was administered prior to ischemia.  This study investigated whether 
prolonged CR beginning after global ischemia would result in lasting protection as 
assessed by performance in the open field, as a measure of functional outcome, and 
hippocampal CA1 neuronal counts.  Adult male Mongolian gerbils were subjected to five 
minute bilateral carotid artery occlusion (I) or sham surgery (S) with tympanic 
temperature maintained at 36.5 ± 0.2ºC during the intra-ischemic period.  After screening 
out gerbils with incomplete ischemia, each of the two surgical groups were randomly 
assigned to control diet (CON) or 30% CR for the duration of the study (60d).  Gerbils 
were tested in the open field on d3, 7, 10, 30 and 60.  Ischemic animals on control diet 
showed a significantly higher level of activity in the open field (impaired habituation) 
compared to SCON gerbils on all test days (p<0.001).  Open field activity was decreased 
9% in the ICR group versus ICON gerbils on d7 (p=0.024), suggesting a transient 
neuroprotective effect.  Open field activity of the SCR gerbils began increasing relative to 
that of SCON gerbils during the last 30 days of the study (p=0.055 on d60), raising the 
question of suitability of the open field test for long-term studies of CR and ischemia.  
Brain sections obtained at d60 were stained with hematoxylin & eosin.  Hippocampal 
CA1 neuron counts were reduced 88% by ischemia (p<0.001), and there was no sparing 
effect of CR.  These findings suggest that prolonged CR administered beginning after 
global ischemia cannot diminish brain injury or enhance long-term recovery. 
ii 
 
ACKNOWLEDGEMENTS 
 Thank you to my supervisor Dr. Phyllis Paterson, I am truly grateful for having 
had the opportunity to work with you, it was a pleasure.  Thank you for all your kindness 
and support.  Thank you to my advisory committee members, Dr. Barry Blakley, Dr. 
Bernhard Juurlink, and Dr. Linda Hiebert, and to my external examiner Dr. Jon Farthing 
for all your wisdom and guidance.   
 Thank you to my fellow graduate students both in the College of Pharmacy and 
Nutrition and the Toxicology Program.  You have been my emotional support team and 
have taught me so much.  I know there is nothing that we can’t accomplish, eventually.  I 
also want to thank our lab technicians, Sonia Cyrenne and Angela Cooper, for all their 
hard work and support.   
 I would like to acknowledge financial support from the Toxicology Graduate 
Program and the College of Pharmacy and Nutrition.  Research funding was provided by 
a grant from the Heart and Stroke Foundation of Saskatchewan.   
 To my family, thank you for your love, support and phone calls. Finally, thank 
you Colin, for your friendship and love, for believing in me and encouraging me. I 
couldn’t have done it without you. 
iii 
 
DEDICATION 
 
 
 
 
 
 
 
This thesis is dedicated to my grandma Norma Heather,  
who instilled in me a life-long love of books. 
 
I have always imagined that Paradise will be a kind of library 
      - Jorge Luis Borges 
iv 
 
TABLE OF CONTENTS 
PERMISSION TO USE................................................................................................................. i 
ABSTRACT................................................................................................................................... ii 
ACKNOWLEDGEMENTS ........................................................................................................ iii 
DEDICATION.............................................................................................................................. iv 
TABLE OF CONTENTS ............................................................................................................. v 
LIST OF TABLES ..................................................................................................................... viii 
LIST OF FIGURES ..................................................................................................................... ix 
LIST OF ABBREVIATIONS ...................................................................................................... x 
 
CHAPTER 1: INTRODUCTION................................................................................................ 1 
1.1 Rationale ...................................................................................................................... 1 
1.2 Hypothesis.................................................................................................................... 3 
1.3 Objectives..................................................................................................................... 3 
 
CHAPTER 2: LITERATURE REVIEW.................................................................................... 5 
2.1 Stroke as a health issue............................................................................................... 5 
2.2 Mechanisms of ischemic brain damage and recovery ............................................. 8 
2.2.1 Mechanisms of acute brain injury.............................................................. 8 
2.2.2 Mechanisms of recovery (brain plasticity) .............................................. 11 
2.3 Caloric restriction (CR)............................................................................................ 13 
2.3.1 Caloric restriction and protective mechanisms against disease ............ 16 
2.3.2 Caloric restriction and ischemic brain damage ...................................... 19 
v 
 
2.4 Animal models of stroke ........................................................................................... 20 
2.4.1 Focal ischemia ............................................................................................ 21 
2.4.2 Global ischemia .......................................................................................... 22 
2.4.3 Bilateral common carotid artery occlusion in Mongolian gerbils ......... 23 
2.4.3.1 Endpoints and standards for assessing hippocampal damage in 
the bilateral common carotid artery occlusion model ..................................... 24 
2.5 Summary.................................................................................................................... 30 
 
CHAPTER 3: MATERIALS AND METHODS ...................................................................... 31 
3.1. Acclimation ............................................................................................................... 31 
3.2 Bilateral common carotid artery occlusion ............................................................ 31 
3.3 Screening for complete ischemia ............................................................................. 32 
3.4 Experimental diets .................................................................................................... 33 
3.4.1 Dietary and euthanasia interventions ...................................................... 35 
3.5 Behavioural testing ................................................................................................... 36 
3.6 Histology .................................................................................................................... 36 
3.7 Statistical analysis ..................................................................................................... 37 
CHAPTER 4: RESULTS ........................................................................................................... 40 
4.1 Surgical outcome ....................................................................................................... 40 
4.2 Dietary and euthanasia interventions ..................................................................... 40 
4.3 Food intake and body weight ................................................................................... 41 
4.4 Open field activity ..................................................................................................... 44 
4.5 Hippocampal CA1 cell counts.................................................................................. 46 
vi 
 
CHAPTER 5: DISCUSSION ..................................................................................................... 50 
 
REFERENCES............................................................................................................................ 59 
APPENDIX A .............................................................................................................................. 80 
APPENDIX B .............................................................................................................................. 81 
APPENDIX C .............................................................................................................................. 84 
APPENDIX D .............................................................................................................................. 86 
 
vii 
 
LIST OF TABLES 
Table 3.1 Experimental diets ............................................................................................ 35 
Table 4.1 Food intake throughout the post-surgical period .............................................. 43 
Table 4.2 Caloric restriction does not alter ischemia-induced death of hippocampal CA1 
neurons at d60: Analysis by option a ............................................................... 48 
Table 4.3 Extent and reliability of hippocampal CA1 neuron loss between left and right 
hemispheres following five min of global ischemia: Analysis by option a ..... 49 
Table D.1 Caloric restriction does not alter ischemia-induced death of hippocampal CA1 
neurons at d60: Analysis by option b ............................................................... 86 
Table D.2 Extent and reliability of hippocampal CA1 neuron loss between left and right   
hemispheres following five min of global ischemia: Analysis by option b ..... 87 
viii 
 
LIST OF FIGURES   
Figure 3.1  Experimental design showing time intervals for all experimental        
procedures ...................................................................................................... 34 
Figure 3.2  Hippocampal CA1 regions selected for histological assessment. .................. 39 
Figure 4.1  Patterns of activity identified in the period following ischemia or sham 
surgery............................................................................................................ 41 
Figure 4.2  Mean (±SEM) body weight throughout the post-surgical period: Analysis by 
option a........................................................................................................... 44 
Figure 4.3  Total distance (mean ± SEM) travelled in the open field on d3, 7, 10, 30, and 
60.................................................................................................................... 45 
Figure 4.4  Percent of distance travelled spent in the outer zone of the open field on d3, 7, 
10, 30, and 60................................................................................................. 47 
Figure A.1  Mean (±SEM) body weight throughout the post-surgical period: Analysis by 
option b .......................................................................................................... 80 
Figure B  Pattern of habituation in the open field by the four experimental groups (option 
a)..................................................................................................................... 83 
Figure C.1  Total distance (mean ± SEM) travelled in the open field on d3, 7, 10, 30, and 
60: Analysis by option b ................................................................................ 84 
Figure C.2  Percent of distance travelled spent in the outer zone of the open field on d3, 
7, 10, 30, and 60: Analysis by option b.......................................................... 85 
 
ix 
 
LIST OF ABBREVIATIONS 
AIN   American Institute of Nutrition 
AMPA   α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid 
ANOVA  Analysis of variance 
BCCAO  Bilateral common carotid artery occlusion 
CA1   Cornu-ammonis 1 
CON   Control 
CR   Caloric restriction 
FOOD trial  Feed or Ordinary Diet trial 
H&E   Hematoxylin and eosin 
I   Ischemia surgery 
ICON   Ischemic control diet 
ICR   Ischemic caloric restriction 
IF   Intermittent fasting 
LSD   Least significant difference 
MCAO  Middle cerebral artery occlusion 
NFκB   Nuclear factor kappa B 
NMDA  N-methyl-D-aspartate 
PEM   Protein energy malnutrition 
ROS   Reactive oxygen species 
S   Sham surgery 
SCON   Sham control diet 
SCR   Sham caloric restriction 
x 
 
xi 
 
SEM   Standard error of the mean 
SIR2   Silent information regulator 2 
SIRT1   Sirtuin 1 
 
CHAPTER 1 
INTRODUCTION 
1.1 Rationale 
 Stroke is the third leading cause of death in developed countries and is a major 
cause of serious long-term disability (Rosamond et al., 2007).  Attempts to develop 
neuroprotective agents with lasting benefit for stroke-induced brain injury have been 
unsuccessful (Ginsberg, 2009; Gladstone et al., 2002).  Mechanisms responsible for the 
cell death cascade following brain ischemia include adenosine triphosphate depletion, 
glutamate excitotoxicity, membrane depolarization, increased intracellular calcium, 
oxidative stress, and inflammation (Harukuni and Bhardwaj, 2006; Dirnagl et al., 1999; 
Juurlink and Sweeney, 1997).  The targeting of neuroprotectants to a single component of 
the complex ischemic cascade is believed to be one major reason for their failure in 
clinical trials (Ginsberg, 2009; Savitz and Fisher, 2007; Fisher and Brott, 2003). Novel 
methods of neuroprotection are needed and should involve combination therapy (Fisher 
and Brott, 2003; Fisher, 2003; Stroke Therapy Academic Industry Roundtable, 1999).  
 Caloric restriction (CR), in which energy intake is reduced by 30-40% while 
sufficient intake of other nutrients is maintained, has been extensively studied for its 
remarkable capacity to extend the average and maximum life span of a number of animal 
species (Young and Kirkland, 2007; Martin et al., 2006; Bordone and Guarente, 2005).  
Caloric restriction can slow age-related alterations in the brain, reduce the incidence of 
age-associated cardiovascular and neurodegenerative diseases, and exert beneficial
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 effects in a variety of neurodegenerative disorders (Ingram et al., 2007; Mattson, 2005; 
Mattson and Wan, 2005; Heilbronn and Ravussin, 2003). 
 We hypothesized that CR should protect against stroke-induced brain damage 
because of its potential for disrupting multiple interrelated pathophysiological events in 
the ischemic cascade.  Caloric restriction is believed to act as a mild stressor that 
increases subsequent stress resistance (de Cabo et al., 2003; Heydari et al., 1996), 
reducing neuronal death due to excitotoxic, oxidative, or metabolic insults (Mattson, 
2005; Mattson and Wan, 2005).  Stress and cell survival proteins, such as heat shock 
protein-70 and sirtuin proteins, are induced by CR (Lin et al., 2000; Yu and Mattson, 
1999).  Caloric restriction can also dampen oxidative damage and the inflammatory 
response (Pamplona et al., 2002; Chandrasekar et al., 2001; Forster et al., 2000; 
Spaulding et al., 1997; Sohal et al., 1994).  Core body temperature is lowered by CR 
(Ferguson et al., 2007; Heilbronn et al., 2006; Lane et al., 1996), which is significant 
because of the marked protective effects of hypothermia against ischemic brain injury 
(van der Worp et al., 2007; Colbourne et al., 1997).  Caloric restriction may also improve 
outcome from stroke by enhancing neuroplasticity mechanisms important to recovery.  
Increased neurogenesis has been reported in response to CR (Lee et al., 2000; Lee et al., 
2002) as has increased production of growth factors, such as brain-derived neurotrophic 
factor, that support structural plasticity (Lee et al., 2000; Lee et al., 2002; Duan et al., 
2003; Duan et al., 2001). 
 There are few studies of CR in experimental stroke models. Decreased brain 
infarct volume and improved neurological deficit score at 24 hours following middle 
cerebral artery occlusion have been reported in rats exposed previously to a three-month 
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intermittent fasting regimen as an alternate method of inducing CR (Yu and Mattson, 
1999). Although this study suggests that a lifestyle incorporating CR might improve 
outcome after stroke, it has some critical limitations when assessed against experimental 
stroke research standards (Stroke Therapy Academic Industry Roundtable, 1999).  To 
demonstrate true efficacy, evidence would need to be obtained with longer-term 
endpoints to establish that CR was not just postponing neuronal death and with the 
addition of functional tasks that are sensitive for detecting persistent disability after focal 
ischemia (Corbett and Nurse, 1998).  Caloric restriction (40%) administered before and 
continuing after global ischemia has also been suggested to improve ischemia-induced 
memory impairments (Roberge et al., 2008a; Roberge et al., 2008b), but these studies 
also acknowledge some methodological limitations.  The clinical relevance of testing CR 
provided prior to stroke can also be questioned, since a chronic energy restriction of 30-
40% is not likely an attainable goal for the human population (Ingram et al., 2006).  
Therefore, we studied CR following bilateral carotid artery occlusion in the gerbil, a 
well-validated model of global ischemia, assessing both hippocampal CA1 (cornu-
ammonis 1) cell death and habituation in the open field. 
1.2 Hypothesis 
 Caloric restriction provided immediately following brain ischemia will result in a 
lasting decrease in brain damage as assessed by performance in the open field, as a 
measure of functional outcome, and hippocampal CA1 neuronal counts.  
1.3 Objectives 
1.  Assess the long-term (60d) effects of post-ischemic CR on functional outcome, as 
measured by the open field test. 
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2.  Assess the long-term (60d) effects of post-ischemic CR on hippocampal CA1 neuronal 
counts.
CHAPTER 2 
LITERATURE REVIEW 
2.1 Stroke as a health issue 
 Stroke, a reduction in blood flow to the brain, is a major cause of death and 
chronic disability in North America.  Ischemic strokes account for about 80% of all 
strokes and are caused when a blood clot causes disruption of blood flow to the brain.  
Approximately 20% are hemorrhagic strokes, and are caused by bleeding into the brain 
when a blood vessel bursts (Heart and Stroke Foundation of Canada, 2006).  There are 
currently more than 50 000 strokes in Canada each year and incidence is anticipated to 
increase as the population ages (Heart and Stroke Foundation of Canada, 2006).  
The effects of a stroke will vary depending on what regions of the brain are 
damaged and the severity of damage.  Stroke survivors can experience weakness and 
paralysis on one or both sides of the body, ataxia, learning impairments, memory loss, 
agnosia, aphasia, and depression, as well as difficulties with breathing, chewing, and 
swallowing.  These statistics illustrate the serious morbidity and mortality of stroke with 
40% of stroke victims being moderately to severely impaired following stroke, and 10% 
of stroke victims being severely disabled and requiring long-term care (Heart and Stroke 
Foundation of Canada, 2006).  Despite the demand for forms of treatment that will reduce 
stroke-induced brain injury, so far attempts to improve stroke outcome have been largely 
unsuccessful (Ginsberg, 2009; Gladstone et al., 2002).
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Intravenous tissue plasminogen activator (tPA) is currently the only validated 
therapy for acute ischemic stroke (Ginsberg, 2009; Savitz and Fisher, 2007; Besancon et 
al., 2008).  Tissue plasminogen activator is injected into the bloodstream where it can 
travel to the site of the clot and start to break it up.  Unfortunately, tPA cannot be given to 
stroke patients more than three hours after the onset of their symptoms because it is no 
longer effective and can increase the risk of bleeding in the brain.  Multiple tests are also 
required to verify the occurrence of ischemic rather than hemorrhagic stroke and the 
majority of patients are not able to receive this treatment in time.  Depending on the 
location of the blood clot, tPA may be injected intra-arterially directly at the site of the 
clot as long as six hours after the onset of symptoms, although this treatment requires 
special equipment and technical expertise that is only available in a small number of 
hospitals.  Other approaches being investigated to establish more rapid reperfusion 
include mechanical clot retrievers and intra-cranial ultrasound (Fisher and Brott, 2003).  
Neuroprotective therapies are developed with the goal of impeding the cell death 
cascade occurring post-ischemia.  These therapies are targeted at specific mechanisms 
involved in ischemic brain damage.  Categories of neuroprotective drugs include 
glutamate receptor antagonists, modulators of the inhibitory transmitter gamma-
aminobutyric acid, sodium and calcium channel blockers, antioxidants, anti-inflammatory 
and anti-apoptotic drugs, and neurotrophins (Thornhill and Corbett, 2001).  Despite the 
success of several of these drugs in animal studies, the results have been negative in 
clinical trials.  One of the reasons suggested for the failure of neuroprotectants in clinical 
trials is that the majority of therapies tested target only one part of the ischemic cascade 
(Ginsberg, 2009; Savitz and Fisher, 2007; Fisher and Brott, 2003).  Alternate methods of 
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neuroprotection are needed and should involve combination therapies, such as the use of 
multiple drugs, to target multiple sites in the ischemic cascade, along with some form of 
reperfusion (Fisher, 2003).  Other forms of treatment need to be investigated in addition 
to targeted drug therapy.  Nutritional status is a modifiable factor that can influence 
stroke outcome (Gariballa, 2000).  However, the majority of nutrition-related stroke 
research to date has focused on reducing risk for developing stroke.  Our laboratory has 
been investigating how nutritional factors can also play a role in determining the extent of 
disability that results from stroke.  
Poor nutritional status is common in stroke patients and has been related to 
increased mortality and reduced functional outcome (Smithard et al., 2007; Gariballa and 
Sinclair, 1998; Gariballa et al., 1998b; Gariballa et al., 1998a).  Protein energy 
malnutrition (PEM), in which protein and energy status are suboptimal, exists in 
approximately 16% of the elderly upon admission for stroke (Davalos et al., 1996; 
Axelsson et al., 1988).  Correlations have been made between PEM at stroke admission 
and increased risk of morbidity and mortality in clinical studies (Gariballa et al., 1998b; 
Gariballa et al., 1998a; Davalos et al., 1996).  Unfortunately these studies are limited by 
study design and small sample size, and a causal link is more difficult to establish in 
clinical studies.  A major international, multi-centre study that had the potential to 
establish causality between PEM and stroke outcome was the FOOD (Feed or Ordinary 
Food) Collaboration Trial.  Preliminary data suggested that compromised baseline 
nutritional status of acute stroke patients was associated with decreased chance of 
survival and increased functional dependency after six months (The FOOD Trial 
Collaboration, 2003).  However, the completed trials failed in one of the study goals, 
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which was to establish that poor nutritional status worsens stroke outcome, due to the 
lack of standardized nutritional assessments (Prosser-Loose and Paterson, 2006; Dennis 
et al., 2005a; Dennis et al., 2005b).  Results from a study in our laboratory were the first 
to show that PEM impairs functional outcome in an animal model of brain ischemia as 
measured by the open field behavioural test (Bobyn et al., 2005).  While poor nutritional 
status appears to negatively affect stroke outcome, little is known about nutritional 
factors that could exert a positive influence on stroke.  This research aims to further our 
knowledge on the effects of nutritional status on long-term stroke outcome by 
investigating the impact of caloric restriction initiated after brain ischemia.   
2.2 Mechanisms of ischemic brain damage and recovery 
2.2.1 Mechanisms of acute brain injury 
While the brain makes up only 2% of the body weight, it receives 20% of the total 
cardiac output and accounts for 20% of total oxygen consumption (Juurlink and 
Sweeney, 1997).  Anoxic conditions within the centre of the infarction (ischemic core) 
cause necrotic cell death to occur within minutes.  While the ischemic core is not 
salvageable, the penumbra, lying between the ischemic core and the unaffected parts of 
the brain, suffers milder injury that may be salvageable or that may progress to infarction; 
this is due to ongoing excitotoxicity and secondary processes such as spreading 
depression, inflammation and apoptosis (Barber et al., 2001).  Thus, neuroprotective 
therapy is aimed at salvaging the penumbral tissue. 
The cell death cascade involved in ischemic brain damage is complex and 
includes adenosine triphosphate (ATP) depletion, glutamate excitotoxicity, membrane 
depolarization, increased intracellular calcium, production of free radicals and 
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inflammation (Harukuni and Bhardwaj, 2006; Juurlink and Sweeney, 1997).  The 
decrease in cerebral blood flow deprives the brain of both glucose and oxygen and leads 
to decreased production of ATP, resulting in anaerobic glycolysis and acidification.  
Energy depletion also results in the depolarization of neuronal and glial membranes, 
releasing glutamate into the extracellular space. Diffusion of glutamate can create 
spreading waves of depolarization in the penumbra, further increasing energy 
consumption.  Excess extracellular glutamate causes overstimulation of N-methyl-D-
aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA), 
and kainate-type glutamate receptors causing a dramatic increase in intracellular calcium, 
sodium and chloride (Hazell, 2007; Lee et al., 2000).  Water passively follows the sodium 
and chloride resulting in edema (Lee et al., 2000).  
Increased intracellular calcium concentrations are thought to be a major factor in 
the development of tissue damage following ischemia.  Calcium accumulation causes 
activation of calcium dependent hydrolytic enzymes which break down membrane 
phospholipids, resulting in the production of reactive oxygen and nitrogen species 
(Hazell, 2007).  Increased production of free radicals can overwhelm endogenous 
antioxidants and lead to oxidative stress and inflammation.  The latter are important 
mediators in brain damage following stroke (Block, 1999).  
The brain is especially susceptible to oxidative damage because it is rich in 
polyunsaturated fatty acids, susceptible to lipid peroxidation, and neurons have relatively 
low levels of antioxidants (Coyle and Puttfarcken, 1993).  Reactive oxygen species 
(ROS) promote destruction of cellular macromolecules and initiate a number of 
signalling pathways that can result in cell death.  Oxidative stress is particularly 
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pronounced during the reperfusion period.  The re-establishment of blood flow brings 
oxygen to the site of the injury, producing superoxide, nitric oxide and peroxynitrite, that 
along with secondary messengers induced by calcium, can cause activation of 
transcription factors such as nuclear factor kappa B (NFκB).  NFκB activation leads to 
the synthesis of a number of other pro-inflammatory cytokines (Bordone and Guarente, 
2005). 
Cytokines and other pro-inflammatory molecules are responsible for the 
accumulation of inflammatory cells in the brain following ischemia.  Activated cytokines 
such as tumor necrosis factor-α and interleukin-1β can lead to tissue damage (Block, 
1999).  Activated microglia, astrocytes, leukocytes and endothelial cells can exacerbate 
tissue damage by producing cytotoxic molecules.  Neutrophils are the first inflammatory 
cells to accumulate in the brain as soon as 30 minutes after ischemia.  Neutrophils can 
cause tissue damage by adhering to the microvasculature and releasing ROS and 
proteolytic enzymes, increasing blood brain barrier permeability and leading to further 
infiltration of inflammatory cells, edema and hemorrhage (Barber et al., 2001; Doyle et 
al., 2008).  
Under ischemic conditions, energy failure and disruption of cellular ion 
homeostasis lead to the death of neurons.  Exactly how neurons die following ischemia is 
controversial (Colbourne et al., 1999).  Cell death can exhibit features of both necrosis 
(plasma membrane failure and cell swelling) and apoptosis (chromatin condensation, loss 
of cell volume, apoptotic bodies and DNA fragmentation).  This may be due to the fact 
that both excitotoxicity and programmed cell death are triggered by ischemia.  
Excitotoxic necrosis is considered the predominant mechanism of ischemic cell death in 
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most cases, but apoptosis may also occur.  Necrosis is thought to predominate in the core 
acutely following ischemia, while apoptosis may predominate in the penumbra at later 
time intervals (Lee et al., 1999).  Whether a cell undergoes apoptosis or necrosis may 
depend on a number of factors such as the severity of injury, neuronal maturity, the 
availability of trophic support and the concentration of intracellular free calcium (Lee et 
al., 1999).  It is important to recognize that therapies designed to attenuate only necrosis 
may result in the promotion of apoptosis (Gladstone et al., 2002). 
2.2.2 Mechanisms of recovery (brain plasticity)  
While ischemia leads to tissue damage and cell death, it also results in the 
activation of endogenous neuroprotective mechanisms (Lee et al., 2000).  Acute 
responses to ischemia include the release of the inhibitory neurotransmitter gamma-
aminobutyric acid and a decrease in NMDA receptor function which act to reduce the 
excitability of circuits and deplete extracellular calcium and sodium.  This results in 
decreased calcium entry into vulnerable neurons (Lee et al., 2000).  
The inflammatory process evolved to fight infection and to aid in tissue repair.  In 
the normal brain, the blood brain barrier blocks the infiltration of inflammatory cells from 
the bloodstream preventing an inflammatory response.  In the ischemic brain, the blood 
brain barrier becomes compromised, allowing inflammatory cells to enter the brain.  
Despite the detrimental effects of excessive inflammation in the ischemic brain, some 
inflammation following stroke may be beneficial (Danton and Dietrich, 2003).  Ischemia-
induced activation of pro-inflammatory molecules and the subsequent inflammatory 
response may aid in repair and the scavenging of necrotic tissue (Danton and Dietrich, 
2003).  As necrotic tissue is resorbed, edema subsides, and circulation to the penumbra 
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can be re-established allowing for functional recovery for some neurons (Lee and van 
Donkelaar, 1995).  
Stroke survivors typically show some degree of functional recovery although the 
extent of recovery is highly variable (Lee and van Donkelaar, 1995; Chen et al., 2002).  
Recovery in the first few days following ischemia may be due to resolution of edema 
and/or reperfusion of the ischemic penumbra (Chen et al., 2002).  Recovery occurring in 
the weeks to months following ischemia is attributed to neuroplasticity (Lee and van 
Donkelaar, 1995; Chen et al., 2002; Bayona et al., 2005; Teasell et al., 2005).  
Neuroplasticity refers to the ability of the brain to reorganize itself, changing its structure 
following tissue damage (Di Filippo et al., 2008).  Neuroplasticity is also required for the 
normal functioning of the central nervous system and occurs during maturation and when 
learning from environmental challenges.  Plasticity occurring post-ischemia has been 
documented in both animal models and human stroke survivors (Di Filippo et al., 2008).  
Neuroplastic changes can occur through a number of mechanisms including the 
unmasking of latent synapses, the formation of new synapses as a result of neuronal 
sprouting, and circuit redundancy where some functions previously performed by 
damaged regions can be taken over by intact regions (Lee and van Donkelaar, 1995; 
Teasell et al., 2005).  Ischemia-induced changes in neurotransmitters, neurotrophins, 
growth factors, and hormones also contribute to neuroplasticity (Johansson, 2000).  
Neurotrophins are thought to be involved in numerous functions within the 
nervous system including aspects of cell proliferation, differentiation, death, survival, and 
plasticity (Johansson, 2000; Arevalo and Wu, 2006).  Brain-derived neurotrophic factor 
(BDNF) plays an important role as a neuronal survival factor, during both development 
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and in neuronal plasticity after brain injury (Bolton et al., 2000; Nawa et al., 1997).  
Increased BDNF following ischemia is believed to promote dendritic sprouting and 
synaptic remodelling which may lead to improved recovery (Lee et al., 2002; Larsson et 
al., 1999; Kiprianova et al., 1999; Ferrer et al., 1998; Tsukahara et al., 1994).  Stem cells 
located in the dentate gyrus can migrate and differentiate into neurons in the 
hippocampus.  Brain derived neurotrophic factor has been shown to enhance 
neurogenesis and survival of newly generated neurons (Lee et al., 2002).  This provides 
another potential therapeutic approach to investigate for aiding in recovery following 
ischemic damage (Johansson, 2000; Schmidt and Reymann, 2002; Abe, 2000). 
2.3 Caloric restriction (CR) 
Caloric restriction (CR) is a nutritional intervention in which energy intake is 
reduced by 30-40% while sufficient intake of other nutrients is maintained (Young and 
Kirkland, 2007).  There are two basic CR paradigms: 1) controlled CR in which animals 
are provided a daily allotment of food that is 30-40% less than the ad libitum 
consumption of a control population, and 2) intermittent fasting (IF) in which animals are 
deprived of food for a full day and are fed ad libitum on intervening days (Anson et al., 
2003; Mattson et al., 2004).  Both methods usually result in a decrease in body weight 
over time although the decrease is often much more pronounced in controlled CR.  Both 
paradigms have reported similar effects including dramatic increases in lifespan and it is 
assumed that both CR and IF act through similar mechanisms (Anson et al., 2003).  
 Energy restriction has been shown to be one of the most efficient and 
reproducible ways to extend average and maximum life span.  In the 1930’s, McCay and 
colleagues showed that a diet that was reduced in energy was able to extend life span in 
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rats (McCay et al., 1935).  Since that time, CR has been shown to extend life span in 
yeast, worms, fruitflies, waterfleas, spiders, and fish (Martin et al., 2006; Bordone and 
Guarente, 2005).  Studies are currently underway to investigate the effects of CR in 
primates and humans.  One study in rhesus monkeys initiated in 1987 found improved 
health and increased life span in monkeys on a 30% CR diet compared to monkeys on 
control diet (Mattison et al., 2003).  Lifespan extension appears to increase progressively 
as energy is reduced up to approximately 50%, beyond which further CR may be 
detrimental and can result in mortality (Mattson, 2005).  The time of onset and duration 
of the CR regimen will also determine the amount by which life span is extended (Martin 
et al., 2006).  
 Although some researchers argue that increases in life span observed in rodents 
on CR are not likely to be observed in humans (Phelan and Rose, 2005), many studies in 
humans suggest a relationship between caloric restriction and good health.  Energy 
restriction occurs naturally in some human populations although most of these 
populations are lacking in protein and micronutrients as well as energy, which does not 
meet the formal definition of CR (Heilbronn and Ravussin, 2003).  One interesting case 
of naturally occurring CR is the centenarians of Okinawa, Japan.  Studies of Okinawan 
centenarians have revealed that while adult Okinawans have the same protein and lipid 
intake as the mainland Japanese, their energy intake is approximately 20% less.  
Interestingly, mortality rates due to cerebrovascular disease, cancer, and heart disease on 
Okinawa were 59%, 69%, and 59% respectively of those for the rest of Japan (Kagawa, 
1978).  However, it is likely there are differences in genetics and environmental factors 
between these populations as well.   
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 The Biosphere 2 in Oracle, Arizona was designed as a man-made ecosystem, 
containing five areas based on natural biomes, to study the natural ecosystems of the 
Earth and the effects of humans within them.  A crew of eight people lived inside 
Biosphere 2 from 1991 to 1993 during which time the Biosphere was sealed off from the 
outside world.  The air, water and food supporting the crew inside Biosphere 2 was 
generated and recycled within the Biosphere.  The crew from Biosphere 2, underwent CR 
when food production inside the enclosed biosphere habitat was less than expected 
(Weyer et al., 2000).  Findings from the Biosphere 2 volunteers confirmed that 30% CR 
imposed for two years could produce many of the expected physiological, hormonal, and 
morphological effects expected from animal studies (Walford et al., 2002).  
 While clinical studies have recently been initiated and some individuals have 
begun to voluntarily restrict themselves in the hope of extending their lives (Speakman 
and Hambly, 2007), CR may be a questionable long-term diet strategy.  In practice, it 
may be very difficult to implement long-term CR in humans, as individuals who overeat 
are often unable to voluntarily limit their food intake despite knowledge of the 
considerable health hazards (Mattson, 2005).  More research also needs to be done on the 
degree of CR necessary for the health benefits seen in rodents as this degree of restriction 
may not be attainable for all people.  
 Most animal research on CR has been done in comparison with a control group 
fed ad libitum.  Under standard laboratory conditions, ad libitum food intake is excessive 
and exercise is limited due to the small cage size (Young and Kirkland, 2007).  Thus, the 
control animals are more likely to represent obese individuals than non-obese individuals.  
This creates difficulties in interpreting the effects of CR, as it is difficult to separate the 
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beneficial effects of weight loss in obese individuals from potentially beneficial effects of 
CR in a normal weight population (Ramsey et al., 2000).  More research is needed to 
determine the effects of CR on non-obese subjects (Bordone and Guarente, 2005).  
 To address these potential problems, research efforts are aimed at developing CR 
mimetics, compounds that can mimic the beneficial effects of CR without actually 
reducing caloric intake (Ingram et al., 2006; Fontan-Lozano et al., 2008).  Some CR 
mimetics currently being studied include 2-deoxyglucose which inhibits glycolysis, 
metformin which enhances the action of insulin, and resveratrol which affects stress 
signalling pathways (Ingram et al., 2006).  
2.3.1 Caloric restriction and protective mechanisms against disease 
Rodents, monkeys and humans exposed to CR have decreased body temperature, 
heart rate, blood pressure, serum glucose and insulin levels (Anson et al., 2003; Fontana 
et al., 2004; Wan et al., 2003; Young et al., 1978), which have been shown to decrease 
the risk of diabetes and cardiovascular disease (Mattson and Wan, 2005).  Caloric 
restriction also decreases lipid accumulation and can decrease low-density lipoprotein 
cholesterol levels while increasing high-density lipoprotein cholesterol levels (Roky et 
al., 2004).  Caloric restriction also reduces the incidence of spontaneous tumors and 
suppresses the development and growth of cancers (Ingram et al., 2007; Mattson, 2005; 
Mattson and Wan, 2005; Heilbronn and Ravussin, 2003).  
 Caloric restriction can also impact the health of the nervous system. Caloric 
restriction has been shown in a number of behavioural tests to prevent age-related 
declines in learning, memory, and motor coordination, thus helping to maintain function 
later into life (Mattson, 2005; Takahashi et al., 2006; Gould et al., 1995).  Caloric 
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restriction can decrease risk and improve existing symptoms for a number of 
neurodegenerative diseases including Alzheimer’s Disease, Parkinson’s Disease, and 
Huntington’s Disease (Duan et al., 2003; Halagappa et al., 2007; Qin et al., 2006; 
Maswood et al., 2004; Duan and Mattson, 1999; Zhu et al., 1999).  Animal models of 
Alzheimer’s Disease have shown that animals maintained on CR exhibit reduced 
neuropathology and reduced learning and memory deficits (Halagappa et al., 2007; Qin et 
al., 2006; Wang et al., 2005).  In animal models of Parkinson’s Disease, IF and CR have 
shown protection against dysfunction and degeneration of mid-brain dopaminergic 
neurons (Duan and Mattson, 1999) and a reduction in behavioural deficits (Maswood et 
al., 2004).  Intermittent fasting has also been shown to delay neurodegeneration and 
motor dysfunction in a mouse model of Huntington’s disease, resulting in increased 
survival (Duan et al., 2003).  
 Two major mechanisms of action have been proposed for CR: 1) increased 
cellular stress resistance and 2) decreased free radical production and oxidative damage 
(Martin et al., 2006; Mattson and Wan, 2005).  Organisms have evolved to respond to 
stressors or challenges in their environment.  Mild or transient exposure to ischemia, 
hypoxia, or other environmental stressors inflicts stress on brain cells which respond by 
enhancing their ability to resist more severe stress.  Preconditioning/ischemic tolerance 
refers to an acquired resistance to ischemia that can result from previous exposure to 
conditioning episodes of mild ischemia (Obrenovitch, 2008; Dirnagl et al., 2003; Farrell 
et al., 2001).  The stress response evoked following ischemic preconditioning involves 
the production of heat shock proteins, antioxidant enzymes, anti-apoptotic factors, and 
growth factors which help to prevent tissue damage during subsequent ischemic attacks 
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(Corbett et al., 2006).  Preconditioning is thought to be a major mechanism whereby CR 
can increase lifespan.  Caloric restriction is thought to act as a mild stressor (Heydari et 
al., 1996; de Cabo et al., 2004) and results in the activation of a number of compensating 
mechanisms.  Evidence that CR increases basal levels of glucocorticoids supports this 
theory (Wan et al., 2003; Patel and Finch, 2002).  Increased levels of stress proteins, such 
as heat shock protein-70 (Yu and Mattson, 1999), neurotrophic factors such as BDNF 
(Lee et al., 2000; Lee et al., 2002; Duan et al., 2003; Duan et al., 2001), and increased 
neurogenesis in the brain (Lee et al., 2000; Lee et al., 2002) have also been reported in 
response to CR. 
 Sirtuin proteins are a type of histone deacetylase that can also increase stress 
resistance.  The induction of sirtuins by CR is thought to be an important mechanism in 
life span extension (Bordone and Guarente, 2005).  In yeast, life span extension by CR 
depends on the upregulation of the silent information regulator 2 (SIR2) gene (Lin et al., 
2000; Kaeberlein et al., 1999).  Caloric restriction also results in the induction of sirtuin 1 
(SIRT1), the mammalian homologue of SIR2, which increases cellular stress resistance, 
thereby protecting against stress-induced cell death (Cohen et al., 2004; Nemoto et al., 
2004).  Sirtuin 1 has also been shown to downregulate NFκB, an important mediator of 
inflammation following ischemia (Yeung et al., 2004). 
 Decreased oxidative damage and inflammatory response have also been 
demonstrated in CR models (Pamplona et al., 2002; Chandrasekar et al., 2001; Forster et 
al., 2000; Spaulding et al., 1997; Sohal et al., 1994).  While overeating increases 
oxidative stress in cells and results in oxidative damage to cellular macromolecules, CR 
reduces the production of ROS, resulting in decreased oxidative damage.  Caloric 
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restriction may suppress oxidative stress through a number of mechanisms including 
reducing the amount of superoxide radicals produced in the mitochondria and by 
increasing the production of chaperone proteins and antioxidant enzymes (Mattson, 
2005).  
2.3.2 Caloric restriction and ischemic brain damage 
 Caloric restriction could be expected to exert marked protective effects in stroke 
because of its ability to modify multiple pathways in the ischemic cascade, as well as 
neuroplasticity mechanisms important to recovery.  These include increasing production 
of stress and cell survival proteins (Lin et al., 2000; Yu and Mattson, 1999), reducing 
oxidative damage and the inflammatory response (Pamplona et al., 2002; Chandrasekar et 
al., 2001; Forster et al., 2000; Spaulding et al., 1997; Sohal et al., 1994), lowering core 
body temperature (Ferguson et al., 2007; Heilbronn et al., 2006; Lane et al., 1996) and 
increasing neurogenesis (Lee et al., 2000; Lee et al., 2002) and production of growth 
factors (Lee et al., 2000; Lee et al., 2002; Duan et al., 2003; Duan et al., 2001). 
 One previous study has examined whether IF was protective when administered 
for three months prior to focal ischemia, a model in which blood flow is reduced to a 
specific brain region.  Yu and Mattson (1999) reported that rats on an IF regimen had 
reduced brain infarct volume and improved functional outcome following middle cerebral 
artery occlusion, a model of focal ischemia in the rat (Yu and Mattson, 1999).  Increased 
levels of the stress protein heat shock protein-70 in striatal cells of CR animals suggest 
the neuroprotective action of CR might be due, in part, to preconditioning.  Although a 
cursory assessment of these data suggest that CR may be a valuable approach for 
improving outcome following stroke, this study has major flaws when assessed against 
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the standards recommended for experimental stroke research (Stroke Therapy Academic 
Industry Roundtable, 1999) (see section 2.4.3.1 below).  One limitation is that outcome 
was only assessed at 24 hours so it is not known if the decrease in brain damage was 
transient or permanent.  In addition, brain function was assessed by a crude neurological 
score (Hunter et al., 2000) instead of the more sensitive tests of functional outcome 
available for focal ischemia models such as a skilled reaching task (Gharbawie et al., 
2005; Farr and Whishaw, 2002).  For example, the staircase test, in which animals reach 
to retrieve a food pellet from a set of stairs, shows great sensitivity in detecting persistent 
disability months after focal ischemia, unlike simpler sensorimotor tasks (Gladstone et 
al., 2002; Corbett and Nurse, 1998).  Caloric restriction (40%) administered before and 
continued after global ischemia has also been suggested to improve ischemia-induced 
memory impairments (Roberge et al., 2008a; Roberge et al., 2008b), however no studies 
have yet examined the effects of CR provided solely during the post-ischemic period.   
 The clinical relevance of testing CR provided prior to stroke can also be 
questioned since the chronic energy restriction of 30-40% that is beneficial in 
experimental animals is not likely an attainable goal for the human population (Ingram et 
al., 2006).  It is of clinical interest, however, to investigate whether CR administered after 
the stroke could form part of a neuroprotective strategy to diminish brain damage and 
disability.   
2.4 Animal models of stroke 
 Appropriate animal models are necessary for the study and treatment of human 
cerebral ischemia.  Cerebral ischemia has been studied in large and small animal species.  
Small animal species (especially rodents) present a number of advantages over large 
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animal species including the lower cost of obtaining and maintaining animals, lower cost 
of procedures due to smaller size, relative genetic homogeneity, close resemblance of the 
cerebrovascular anatomy and physiology to that of higher species and greater 
acceptability (Ginsberg and Busto, 1989).  Procedures in small animals can also be 
controlled so that injury is more reproducible and less variable than in larger species.    
2.4.1 Focal ischemia 
 In focal ischemia, blood flow is reduced to a very specific brain region producing 
an ischemic core of unsalvageable tissue and the surrounding penumbra which has the 
potential to be saved (Traystman, 2003).  Focal ischemia models are often used because 
of their relevance to human stroke.  Focal models can involve either permanent or 
transient artery occlusion.  The most common focal ischemia model involves occlusion of 
the middle cerebral artery.  Middle cerebral artery occlusion (MCAO) results in a 
reduction in blood flow in the striatum and cortex.  Focal ischemia models are more 
technically demanding than global ischemia models.  Vessel occlusion is most often 
accomplished with the use of clips, but can also be accomplished by electrocoagulation 
and photochemical irradiation.  Other focal ischemia models include blood clot embolism 
and intraluminal filament placement within the carotid artery and ligature snare 
placement around the middle cerebral artery (Traystman, 2003).  Occlusion of the 
common carotid artery in conjunction with that of the middle cerebral artery aids in 
further reducing blood flow to the area.  Injection of the vasoconstrictor endothelin into 
the cortex and striatum and adjacent to the middle cerebral artery, into the forelimb 
region of the motor cortex, has also been used to reduce blood flow (Windle et al., 2006).  
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2.4.2 Global ischemia 
Global ischemia occurs when cerebral blood flow is reduced throughout the brain 
causing neuronal injury to selectively vulnerable areas.  Global ischemia models involve 
a brief termination of cerebral blood flow (5-15 minutes) followed by reperfusion.  While 
global ischemia models have been criticized for mimicking human cardiac arrest rather 
than focal stroke, they share many of the same pathophysiological mechanisms (Harukuni 
and Bhardwaj, 2006) and provide more consistent injury (McBean and Kelly, 1998).  
Thus, global stroke models are useful for understanding mechanisms of tissue damage 
and evaluating the efficacy of interventions before advancing to focal models where more 
variables must be controlled (Ginsberg and Busto, 1989; Small and Buchan, 2000).  The 
three most common models of global ischemia are the four-vessel occlusion (4-VO) and 
two-vessel occlusion (2-VO) models in the rat and bilateral common carotid artery 
occlusion (BCCAO) in the gerbil. 
Pulsinelli and Brierley (1979) developed the 4-VO model of reversible forebrain 
ischemia in rats.  The 4-VO model is highly technically demanding and involves a two-
step process to produce ischemia.  Anterior vertebral arteries are cauterized, followed the 
next day by occlusion of the common carotid arteries.  The 4-VO model results in 
extensive brain injury including damage in the striatum, hippocampus, and neocortex and 
commonly results in increased mortality.  
The 2-VO model of ischemia developed by Eklof and Siesjo (1972) involves 
bilateral common carotid artery occlusion coupled with systemic hypotension to produce 
ischemia.  Two-vessel occlusion in the rat is a much simpler surgery and produces 
consistent and reliable damage.  Inducing hypotension during occlusion is a critical part 
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of the technique.  The 2-VO model produces injury that is similar to the 4-VO model 
with damage occuring within the hippocampus, neocortex and caudoputamen as a 
function of occlusion time.  
2.4.3 Bilateral common carotid artery occlusion in Mongolian gerbils 
 Until recently, the gerbil model of global ischemia, in which global forebrain 
ischemia is produced by BCCAO, was used extensively in stroke research.  Bilateral 
common carotid artery occlusion requires minimal surgical intervention and has 
historically produced very consistent, reproducible injury to the hippocampal CA1 region 
(Corbett and Nurse, 1998; Small and Buchan, 2000).  Consistency of the injury had been 
attributed to the gerbil’s unique vascular anatomy as they lacked posterior 
communicating arteries, and therefore had an incomplete Circle of Willis (Ginsberg and 
Busto, 1989). 
 Unfortunately, recent work has discovered that cerebral vasculature in the North 
American commercial supply of gerbils is changing.  Experiments in our laboratory 
(Bobyn et al., 2005; Ji et al., 2008) and others (Laidley et al., 2005; Wang et al., 2002; 
Breuer and Mayevsky, 1992) have shown increased variability in hippocampal damage 
and functional effects following BCCAO.  In 2005, Laidley and colleagues compared the 
vasculature of gerbils from Charles River Canada (our current supplier) with those from 
High Oak Farms (ON, Canada).  Approximately 61% of animals from Charles River 
were found to have a complete (22.7%) or partial (38.6%) Circle of Willis due to the 
presence of significant posterior communicating arteries.  These animals had less severe 
CA1 loss as well as attenuated behavioural deficits in the open field after undergoing 
BCCAO compared to those with no posterior communicating arteries.  Posterior 
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communicating arteries were also found in gerbils from High Oak Farms although to a 
lesser extent (2.6% with bilateral and 13.2% with unilateral); High Oak Farms is no 
longer a reliable commercial source of gerbils.  Similar results have since been reported 
in gerbils from other major North American suppliers (Seal et al., 2006). 
 A screening technique based on activity monitoring was developed in our 
laboratory as a temporary solution to this problem, and this approach was used for the 
current study to ensure consistent forebrain ischemia.  Following ischemia, animals 
exhibit transient locomotor hyperactivity for up to 30 hours (Corbett and Nurse, 1998).  
This hyperactivity is a reliable indicator of ischemic severity (Corbett et al., 1997; 
Mileson and Schwartz, 1991).  Considering the possibility for both false positive and 
false negative results, a previous study in our laboratory demonstrated that the monitoring 
method correctly categorizes 85% of animals tested (M.I. Harmon et al., unpublished 
observations) although this estimate is limited by a small sample size.  Although 
screening greatly reduces experimental variability, the disadvantage is that a much larger 
sample size is required in order to replace those that fail to meet the criteria.   
2.4.3.1 Endpoints and standards for assessing hippocampal damage in the bilateral 
common carotid artery occlusion model 
 As with the other global ischemia models mentioned above, BCCAO in the gerbil 
results in neuronal cell death in several vulnerable brain structures, including the 
hippocampal CA1 region, the neocortex, and striatum.  Cell death does not occur 
immediately but is delayed with most cell death occurring 3-7 days following ischemia.  
Delayed cell death provides a window of opportunity when intervention may reduce cell 
loss and associated learning and memory deficits (Colbourne and Corbett, 1994).  This 
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delayed and selective cell death has been well characterized and is similar among all 
global ischemia models (Small and Buchan, 2000).  The extent of brain injury is usually 
assessed histologically by counting viable hippocampal CA1 neurons since these neurons 
are highly susceptible to global ischemic injury.  
Five minutes of global ischemia results in extensive loss of CA1 neurons in the 
hippocampus by seven days after surgery (Corbett and Nurse, 1998; Colbourne and 
Corbett, 1994; Nurse and Corbett, 1994).  Cell death in the CA1 region following global 
ischemia is highly reliable and damage is more consistent than in other brain regions.  
The distinctive distribution and large size of CA1 neurons also makes them relatively 
easy to quantify (Corbett and Nurse, 1998).  Histological and behavioural endpoints for 
the gerbil BCCAO model have been developed and are well established.  Studies have 
shown a relationship between damage in the CA1 region of the hippocampus and deficits 
in spatial learning.   
The results obtained with rodent models of stroke are only reliable when 
experiments are carried out according to the current recommendations for quality 
preclinical stroke research (Gladstone et al., 2002; Stroke Therapy Academic Industry 
Roundtable, 1999).  While histological endpoints, such as cell counts and infarct volume, 
are frequently used to assess the efficacy of potential therapeutic interventions, it is 
important that functional endpoints are also assessed (Stroke Therapy Academic Industry 
Roundtable, 1999; Corbett and Nurse, 1998; Colbourne and Corbett, 1995).  Neurons that 
have a normal histological appearance can be functionally abnormal (Corbett and Nurse, 
1998), and lesion size does not always correlate with functional impairment (Stroke 
Therapy Academic Industry Roundtable, 1999).  Functional recovery is the major 
25 
 
endpoint in clinical trials and can persist for months after ischemia.  Therefore it is 
important that functional endpoints be assessed in combination with histological 
endpoints (Gladstone et al., 2002; Corbett and Nurse, 1998).   
Behavioural tests such as the open field test, T-maze and radial arm maze have 
demonstrated that gerbils exposed to global ischemia show profound learning deficits 
(habituation and working memory impairments) similar to humans (Mileson and 
Schwartz, 1991; Colbourne and Corbett, 1995).  These behavioural tests are used to 
assess functional outcome and have been shown to be reliably sensitive to ischemia 
(Colbourne and Corbett, 1994; Colbourne and Corbett, 1995; Colbourne et al., 1998a).   
The open field test is a useful functional test for global ischemia research because it is 
sensitive to differences in CA1 injury and can differentiate groups treated with beneficial 
therapies from non-treated ischemic controls.  Other benefits of the open field test are 
that test sessions are relatively short, it is not labour intensive, and functional deficits can 
persist for months (Corbett and Nurse, 1998).  
Immediately following stroke surgery, gerbils progress through a series of 
changes in their activity patterns.  As the gerbils recover consciousness they enter a quiet 
period during which they often exhibit a characteristic hunching (Corbett and Nurse, 
1998).  This quiet period is followed by a period of heightened locomotor activity, which 
as indicated above, can be used as an indicator of ischemic severity (Mileson and 
Schwartz, 1991). This period lasts for 24-48 hours after surgery, after which activity 
levels return to normal.  
Following the initial hyperactivity phase, a more chronic form of heightened 
locomotion occurs that can only be detected when animals are placed in a novel 
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environment.  When placed in an open field, ischemic gerbils display significantly 
elevated locomotion compared to sham-operated gerbils, which has been interpreted as an 
inability to habituate to a novel environment (Corbett and Nurse, 1998).  Sham-operated 
animals will gradually habituate to the novel environment, resulting in a decrease in 
activity, while animals exposed to global ischemia will continue to exhibit high activity 
levels.  This is believed to be due to a spatial learning deficit (Colbourne et al., 1998b; 
Wang and Corbett, 1990).  If testing is repeated regularly, ischemic animals will 
gradually habituate and activity levels will decrease; differences in activity levels can be 
seen for months if testing is intermittent (Corbett and Nurse, 1998).  Ischemia-induced 
hyperactivity in novel environments has been found to correlate with CA1 cell death in 
the hippocampus (Corbett and Nurse, 1998; Mileson and Schwartz, 1991; Nurse and 
Corbett, 1994).   
 Some investigators suggest that anxiety also influences open field activity 
following ischemia (Plamondon and Khan, 2005).  An unfamiliar environment may be 
mildly anxiogenic as animals may consider it potentially dangerous.  Upon exposure to a 
novel environment animals may initially exhibit decreased exploratory behaviour, 
increased heart rate, urination, defecation, and plasma corticosterone levels (Palanza, 
2001).  It has been suggested that ischemia results in increased activity because it causes 
disinhibition to explore novel environments (Plamondon and Khan, 2005).  Rodents are 
known to prefer the periphery of the open field to the centre, a behaviour known as 
thigmotaxis.  Increased time spent in the periphery of the open field may indicate 
increased anxiety while increased time spent in the centre of the open field is considered 
anxiolytic (Calabrese, 2008; Prut and Belzung, 2003).  Thus, it is possible that measuring 
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activity in the centre relative to that in the periphery of the open field might yield 
additional information about functional outcome after global ischemia.  This approach 
has, however, never been validated in a global ischemia model. 
 The T-maze is another useful behavioural test that can be used to detect deficits in 
working memory following global ischemia in the gerbil (Corbett and Nurse, 1998).  
Animals are tested in two trials.  Information learned in the first trial must be 
remembered in the second trial in order for the animal to be successful.  The Win-Shift 
strategy is the most commonly used application of the T-maze.  On the first trial, the 
animal is allowed access to one arm of the maze to receive a food reward.  On the second 
trial, both arms of the maze are accessible, but the animal will only receive a reward if it 
enters the opposite arm. In the Win-Stay strategy, the animal has to choose the same arm 
that it entered on the previous trial in order to receive the reward.  This strategy is much 
more difficult for the gerbil to learn as revisiting of the same arm is contrary to the 
gerbil’s normal foraging behaviour (Babcock and Graham-Goodwin, 1997).  Delaying 
the time between trials also increases the difficulty of the test (Corbett and Nurse, 1998).  
Following ischemia, impairments in working memory are indicated by decreased choice 
accuracy and increased time to reach criterion (Corbett and Nurse, 1998; Farrell et al., 
2001; Babcock and Graham-Goodwin, 1997).  One disadvantage of this test is that the 
use of food rewards may confound results in nutritional studies (Prosser-Loose et al., 
2007). 
 The radial arm maze has also been used to detect reference and working memory 
deficits in the gerbil following global ischemia although it has been noted that these 
deficits recover over time (Corbett and Nurse, 1998; Block, 1999).  The radial arm maze 
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presents the same disadvantage as the T-maze for nutritional studies as it also involves 
the use of food rewards.  A second major disadvantage of both the T-maze and radial arm 
maze is that they are highly time consuming and labour intensive compared to the open 
field test (Corbett and Nurse, 1998).  Because the open field test does not require 
extensive training and test sessions are short, it is a valuable tool for studies with multiple 
groups or large numbers of animals.  Thus the open field test was chosen for use in this 
study. 
 In addition to the need discussed above of employing functional testing as well as 
histological assessment, animal studies should include long-term endpoints, as some 
treatments have been found to only postpone cell death (Corbett and Nurse, 1998).  
Neuroprotection observed in many animal studies have, for the most part, been based on 
experiments that used short survival times (1-7 days) with histology (cells counts or 
infarct volumes) as the only endpoint.  Studies with longer survival times should be better 
indicators of whether the effects of interventions are truly neuroprotective (Stroke 
Therapy Academic Industry Roundtable, 1999).   
 Specific physiological variables must also be carefully controlled to ensure that 
the model induces consistent brain damage.  In particular, brain temperature is a critically 
important variable and should be maintained in a constant normothermic range as it can 
have striking effects on stroke outcome (Small and Buchan, 2000).  Hyperthermia can 
exacerbate ischemic damage while hypothermia can provide robust protection against 
ischemic damage (van der Worp et al., 2007; Colbourne et al., 1997).  Ignoring this key 
information is one of the reasons thought to account for the failure of neuroprotective 
treatments in clinical studies.  
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2.5 Summary  
 Based on evidence that CR could modify pathways in the ischemic cascade as 
well as enhance neuroplasticity mechanisms important to recovery, we investigated 
whether CR provided solely after brain ischemia could decrease brain injury and improve 
functional recovery.  Previous studies have suggested some benefit when a CR regimen 
was initiated prior to ischemia, but to date no studies have examined the effects of CR 
solely after ischemia.  The gerbil BCCAO model was used to address this question as it is 
very well-characterized.  Histological and behavioural endpoints have been well 
established for the gerbil BCCAO model and studies have shown a relationship between 
damage in the CA1 region of the hippocampus and deficits in spatial learning.  Due to the 
emerging problem of changing brain vasculature in the gerbil that has threatened the 
reliability of this model, we have utilized a method of hyperactivity screening to ensure 
consistent forebrain ischemia. 
 
CHAPTER 3 
MATERIALS AND METHODS 
3.1. Acclimation 
 Adult male Mongolian gerbils (Meriones unguiculates, Charles River Canada, 
QC, Canada), age 11 to 12 weeks, were acclimated for ten days at 22ºC with a 12 hour 
light/dark cycle in shoebox cages with free access to food and water.  Animals were 
group housed for three days and were then separated into individual cages for the 
remaining acclimation and experimental period.  Regular rat chow was provided for the 
first three days while the animals were group housed, and purified control diet (see 
section 3.1.4) was provided for the remaining seven days.  All animal care and 
procedures adhered to the Canadian Council on Animal Care guidelines and were 
approved by the University of Saskatchewan Committee on Animal Care and Supply.  
Following acclimation, animals were assigned to sham surgery or global ischemia, 
induced by BCCAO.  
3.2 Bilateral common carotid artery occlusion 
 Anaesthesia was induced with 4.0% isoflurane and 1L/min oxygen and was then 
reduced down to 2.5-3.0% isoflurane and 1L/min oxygen for the duration of the surgery.  
Both common carotid arteries were isolated through a ventral midline incision.  A 
surgical silk thread was passed under both arteries allowing them to be gently lifted and 
isolated.  Once the arteries were isolated, they were occluded for five minutes with
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 microaneurysm clips.  Occlusion and reperfusion were visually verified, as this is an 
ischemia-reperfusion model.  During occlusion, brain temperature was estimated via a 
tympanic probe (Barnant Type T Digi-Sense Thermometer) and maintained at 
36.5±0.2ºC  by wrapping a Mul-T-Pad® water heated blanket (Global Medical Products, 
Inc., Burlington, ON , Canada) around the gerbil’s head.  A rectal probe was used to 
monitor body temperature, which was maintained with a homeothermic blanket (Harvard 
Apparatus Canada, St. Laurent, QC, Canada).  The incision was then closed and local 
anaesthetic (Xylocaine) applied.  Sham surgery was identical to ischemia surgery with 
the exception of artery occlusion.  Following surgery, gerbils were placed in individual 
cages and observed for two hours.  A heat lamp was placed over part of the cage to keep 
the gerbil warm but with the opportunity for them to move away from the heat when 
mobile.  Animals were then returned to cages to be monitored for activity.  Any animals 
showing seizures (n=1) were excluded from the study. 
3.3 Screening for complete ischemia 
 After a two hour recovery period, gerbils were monitored for a 20 hour period to 
determine the success of ischemia surgery. Five grams of purified control diet (see 
section 3.1.4) and water ad libitum were provided during this period.  Ischemic animals 
are known to exhibit heightened activity for up to 30 hr post-ischemia (Corbett and 
Nurse, 1998) and this hyperactivity can be used as a tool to screen out incomplete 
forebrain ischemia.   
 Gerbils were monitored by an Opto-M3 Activity Meter (Columbus Instruments, 
Columbus, OH, USA) using infrared beam interruption in two-dimensions.  The 
accumulated interruption counts were recorded every 15 minutes.  The following criteria 
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were used to identify animals with severe forebrain ischemia: 1) an activity level greater 
than three standard deviations above the mean activity level of a pool of laboratory sham 
animals (n=30) and 2) hyperactivity had to be sustained for the entire 20 hour monitoring 
period (M.I. Harmon et al., unpublished observations).   
3.4 Experimental diets 
 Following activity monitoring, each of the two surgical groups were randomly 
divided into control (CON) or caloric restriction (CR) groups, generating four 
experimental groups; 1) sham - control diet (SCON), 2) sham - caloric restriction (SCR), 
3) ischemia - control diet (ICON) and 4)  ischemia - caloric restriction (ICR).  The 
experimental design is shown in Figure 3.1.  Control and CR diets (Dyets Inc. Bethlehem, 
PA, USA ) were based on the AIN-93M rodent diet (Reeves et al., 1993), but did not 
contain the antioxidant tert-butylhydroquinone because of its potential to confound 
studies involving oxidative stress and inflammation (Table 3.1).  The two diets were 
isocaloric, but CR groups were fed 30% less food each day than their respective CON 
groups to create 30% energy restriction.  The diet fed to the CR groups was formulated to 
ensure that intake of essential nutrients (protein, fat, vitamins and minerals), considering 
the 30% reduction in food intake, was the same as that of the CON group.   
 The CON group had free access to the control diet.  The amount of CR diet to be 
supplied to the SCR and ICR groups was calculated separately throughout the experiment 
since food intake can differ between ischemic and sham gerbils following their respective 
surgeries (Bobyn et al., 2005).  For the first three days following surgery, SCR and ICR 
animals were fed 30% less than the average food intake observed in a previous 
experiment of group-housed SCON and ICON gerbils, respectively.  Beginning on day 
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four following surgery, SCR and ICR gerbils were fed 30% less than the actual average 
intake consumed in the current study by the respective control group during the previous 
day.  Because of the experimental design in which animals were continually added to the 
experiment, these estimates of food intake were based on an increasing sample size as the 
study progressed.  Daily food intake and weekly body weight were recorded over the 60 
day study period. 
 
 
Open field 
testing 
d3,7,10,30,60 
Histological 
analysis of 
hippocampal 
CA1 neurons 
d60 
Figure 3.1 Experimental design showing time intervals for all experimental procedures. 
BCCAO: bilateral common carotid artery occlusion.  SCON: sham animals with control 
diet; SCR: sham animals with CR; ICON: ischemic animals with control diet; ICR: 
ischemic animals with CR. 
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Table 3.1 Experimental diets 
Component Control (CON) 
g/kg 
Caloric Restriction (CR) 
g/kg 
Vitamin Free Casein 140 199 
L-Cystine 1.8 2.6 
Sucrose 100 142 
Cornstarch 465.7 341.8 
DYETROSE 155 119 
Soybean Oil a 40 57 
Cellulose 50 71 
Mineral Mix b  35 50 
Vitamin Mix c 10 14 
Choline Bitartrate 2.5 3.6 
a Soybean oil without tert-butylhydroquinone. 
b AIN-93M mineral mix (Reeves et al., 1993). 
c AIN-93M vitamin mix (Reeves et al., 1993). 
 
3.4.1 Dietary and euthanasia interventions 
 Following surgery, it was noticed that some CR animals (both sham and 
ischemic) were losing weight too rapidly, were losing an excessive amount of weight or 
were showing signs of weakness.  This concern was discussed with one of the University 
veterinarians.  A humane endpoint for euthanasia was identified as well as an 
experimental intervention strategy to be used if needed.  Animals were monitored daily, 
and gerbils were humanely killed if they showed weakness, poor grooming or other signs 
of poor health.  A decision was made that if 10% of the calorically restricted animals 
(7/72) had to be euthanized, the following intervention strategy was to be invoked: any 
animal that lost >35% of body weight, showed a period of excessive rate of weight loss 
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(>16% in one week) or showed signs of poor grooming or weakness was to be fed 5% 
more diet each day until the end of the study. 
3.5 Behavioural testing 
To test for chronic habituation impairments, gerbils were placed in an open field 
(75 X 75 X 75 cm) on d3, 7, 10, 30 and 60 post-ischemia (Colbourne and Corbett, 1995).  
The open field was located in a secluded room, and environmental cues (e.g. 
experimenter, shelving, lighting) were kept constant during testing.  Once in the open 
field, gerbils were monitored by video tape and analyzed (EthoVision Basic, Noldus 
Information Technology) to determine total distance travelled and preferred location of 
activity (i.e. periphery vs. centre).  The periphery or outer zone was designated as the 
outside 12 cm of the open field. Each test session lasted 10 minutes.   
3.6 Histology 
 Following open field testing on day 60, gerbils were anaesthetized and perfused 
transcardially with heparinized saline (4 min at 12 mL/min), followed by 10% neutral 
buffered formalin (8 min at 12 mL/min).  To minimize the occurrence of dark neuron 
artifact (Cammermeyer, 1962), intact heads were fixed in formalin for 24 hours. Brains 
were then gently removed and stored in formalin for at least 24 hours prior to paraffin 
embedding.  Brains were cut into 6 μm sections and stained with hematoxylin and eosin 
(H&E).  Slides were blinded to prevent assessment bias, and brain damage was assessed 
histologically by counting hippocampal CA1 neurons.  Cells were counted if they looked 
viable, were non-eosinophilic, and had a defined cell membrane and nucleus.  Neurons 
were counted bilaterally at 400x magnification in three sections representing the entire 
anterior-posterior axis of the hippocampus.  Neurons were counted in medial, middle, and 
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lateral sectors (sector length = 0.2mm) of the hippocampal CA1 region at -1.7 and -2.2 
mm relative to bregma and in a single sector (middle CA1) at -2.7 mm from bregma 
using a 200µm square (10X10) microscope grid using a method modified slightly from 
that of (Colbourne and Corbett, 1995) (Figure 3.2).  Neuron counts were summed over 
left and right hemispheres.  Treatment effects were analyzed for each of the 3 
hippocampal regions and for the total neuron counts summed for all 3 sectors. 
3.7 Statistical analysis 
 All data are presented as mean ± SEM.  Food intake for each week (or portion of 
a week) and hippocampal CA1 cell counts were analyzed by two-factor ANOVA.  Body 
weight and open field data were analyzed by three-factor repeated measures ANOVA.  
Two factor ANOVA followed by a posthoc test (least significant difference) was used for 
body weight and open field analysis on individual days when appropriate.  A probability 
value of ≤0.05 was considered to be statistically significant. The SPSS 16 for Windows 
(SPSS Inc., Chicago IL) version was used for all analysis.   
 To determine if the 5% extra diet that was fed to 3/17 SCR gerbils and 4/14 ICR 
gerbils confounded the experimental results, all data (with exception of food intake) were 
analyzed twice: 1) One analysis included all animals for as long as data could be obtained 
(option a) and 2) the second analysis included only animals that completed the study as 
planned (excluding animals that required intervention or died prematurely) (option b).   
 Open field data were analyzed by three-factor repeated measures ANOVA to 
identify any treatment by diet by day interactions.  This analysis cannot be applied to any 
animals with missing data, that is, those gerbils that did not complete all five open field 
test sessions (those that had to be euthanized or simply missed a test) therefore, these 
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animals were excluded from the analysis.  Sample sizes for the three-factor repeated 
measures ANOVA are as follows: option a: SCON, n=12, SCR, n=13, ICON, n=13, ICR, 
n=12; option b: SCON, n=12, SCR, n=10, ICON, n=13, ICR, n=8.  Because of the 
importance of testing whether the intervention influenced results, these animals were 
included in a subsequent 2-factor ANOVA used to evaluate effects on individual days.  
This larger sample size is presented in Figure 4.3 and Figure C.1. Since the results from 
statistical analysis did not differ between the two options for any endpoint, only the 
results from option a are presented in the main body of the thesis.  Note that option a has 
a higher sample size, therefore increasing statistical power.  The exception is for food 
intake, for which data presented are from option b analysis.  It was not possible to use 
option a for food intake data due to incomplete data from the time intervals analyzed.  All 
data analysis from option b are available in appendices B-D.   
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 Figure 3.2 Hippocampal CA1 regions selected for histological assessment.  Level A,      
~-1.7mm relative to bregma; Level B, ~-2.2mm relative to bregma; Level C, ~-2.7mm 
relative to bregma.  Permission was obtained from The Journal of Neuroscience to reprint 
this figure.  
 
 
39 
 
CHAPTER 4 
RESULTS 
4.1 Surgical outcome 
 All animals met criteria set for brain temperature during the ischemic period.  One 
animal was excluded from the study because of subsequent seizures.  Three animals died 
during surgery, two due to ruptured arteries, and one due to cessation of breathing.  
Thirty-two out of a total of 66 (48.5%) animals that underwent bilateral carotid artery 
occlusion did not meet the criteria for complete forebrain ischemia based on activity 
monitoring and were excluded from the study.  Figure 4.1 shows representative activity 
patterns for 20 hr following ischemia or sham surgery.  Activity patterns observed in 
ischemic animals can be divided into three categories 1) complete ischemia, in which the 
pattern of persistent hyperactivity exhibited met the established criteria, 2) incomplete 
ischemia in which low activity was observed, and 3) incomplete ischemia, in which 
gerbils exhibited initial hyperactivity that was not sustained over the monitoring period.   
4.2 Dietary and euthanasia interventions 
 After 10% of the calorically restricted animals had to be euthanized due to 
weakness, poor grooming or other signs of poor health, the planned dietary intervention 
became necessary.  As noted in section 3.14, any gerbil that showed excessive weight 
loss (>35%), a period of excessive rate of weight loss with poor grooming or weakness, 
or only the clinical signs were fed 5% more diet than calculated for each day until the end 
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of the study.  This intervention strategy was required in 3/17 SCR gerbils and 4/14 ICR 
gerbils.  This prevented any further deaths or abnormal clinical signs, with the exception 
of one animal (ICR) for which intervention was likely too late.   
 
Figure 4.1 Patterns of activity identified in the period following ischemia or sham 
surgery.  Representative patterns of activity are shown for:  sham surgery;  
complete forebrain ischemia identified by persistent hyperactivity;  incomplete 
forebrain ischemia identified by low activity;  incomplete forebrain ischemia 
identified by initial hyperactivity that was not sustained throughout the 20 hr testing 
period.  
 
4.3 Food intake and body weight  
 Food intake following surgery was divided into the following time periods: d1, 
d2, d3, d4-7, d8-14, d15-21, d22-28, d29-35, d36-42, d42-49, d50-56, and d57-60.  Days
41 
 
 1, 2 and 3 were analyzed separately because food allotment for the SCR and ICR groups 
was calculated differently on d1-3 than for the rest of the study (see section 3.1.4). and 
because the pattern of food intake varied within this time interval.   
 Throughout the 60 day study, and as expected according to treatment, the food 
intake of CR gerbils was significantly less than that of animals fed the CON diet 
(p<0.001) (Table 4.1).  Ischemia significantly depressed food intake on d1 (p=0.023) and 
significantly increased food intake over d4-7 (p=0.017), d8-14 (p<0.001) and d15-21 
(p=0.003).  The effect of ischemia on food intake disappeared by d22-28 (p > 0.05).  
There was no significant interaction between surgery and diet at any of the timepoints 
tested (p>0.05).  Table 4.1 also shows that CR gerbils were underfed during the first three 
days of the study when their food allotment was being based on data from a previous 
study.  Average energy reduction during the first three days of the study was 41%, 56%, 
and 40% for SCR animals and 71%, 55% and 55% for ICR animals.  Between d4 and the 
end of the study, when food allotment in the CR groups was calculated relative to actual 
intake of the respective CON group, average energy reduction was at the desired level, 
being 31.3% for the SCR group and 29.9% for the ICR group.   
 Figure 4.2 presents the mean (±SEM) body weight for each group throughout the 
experiment.  Three-factor repeated measures ANOVA revealed a significant effect of diet 
(p<0.001, between subject effects) and week, (p<0.001, within-subject effects) as well as 
a significant diet by week interaction (p<0.001, within subject effects).  The interactions 
of surgery by week (p=0.606) and diet by surgery by week (p=0.677) were not 
significant.  Mean initial body weight (±SEM) was not statistically different among 
groups upon entry into the study, but from d7 until perfusion (d60), mean body weight of 
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CR gerbils was significantly lower than that of gerbils on the CON diet (p<0.001, 
between-subject effects).  Body weight data from option b are shown in Appendix A (Fig. 
A.1). 
Table 4.1 Food intake throughout the post-surgical period 
 Food intake (g) 
Days following surgery  SCON SCR* ICON ICR* 
1   4.2±0.3 2.4±0.1 3.8±0.5# 1.0±0.1# 
2   4.3±0.2 1.9±0.0 4.4±0.4 2.0±0.0 
3   4.9±0.3 2.9±0.0 5.4±0.6 2.4±0.0 
4-7   17.5±0.8 12.2±0.1 20.3±1.1# 13.7±0.5# 
8-14   30.8±1.0 20.6±0.1 34.6±1.0# 24.2±0.7# 
15-21   30.9±1.0 20.0±0.3 33.2±1.1# 23.4±0.2# 
22-28   31.6±1.0 20.8±0.3 31.4±1.0 21.6±0.1 
29-35   31.3±0.9 20.9±0.3 30.8±1.0 20.2±0.2 
36-42   31.3±1.1 21.3±0.1 32.2±0.9 23.5±0.3 
43-49    32.1±1.2 22.0±0.1 32.2±0.8 22.5±0.1 
50-56   32.5±1.5 22.4±0.2 31.9±1.1 21.5±0.2 
57-60   13.9±0.6 10.0±0.1 13.7±0.5 9.7±0.1 
Data are expressed as mean ±SEM; SCON, n=14; SCR, n=10; ICON, 
n=15; ICR, n=10.  Data were analyzed by two-factor ANOVA.  *Food 
intake was significantly decreased at all timepoints in CR animals as 
compared to CON animals (p<0.001).  #Ischemia independently 
decreased food intake on d1 (p=0.023) and increased food intake 
during d4-7 (p = 0.017), d8-14 (p<0.001) and d15-21 (p=0.003).  
SCON: sham animals with control diet; SCR: sham animals with CR; 
ICON: ischemic animals with control diet; ICR: ischemic animals 
with CR. 
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Figure 4.2 Mean (±SEM) body weight throughout the post-surgical period: Analysis by 
option a.  Initial body weight on the day of surgery (shown as d0) was not significantly 
different among groups, but from d7 onwards, CR gerbils weighed significantly less than 
gerbils on the CON diet (p<0.001), as determined by two-factor ANOVA and LSD post 
hoc tests.  SCON: sham surgery with control diet; SCR: sham surgery with CR; ICON: 
ischemic surgery with control diet; ICR: ischemic surgery with CR.  
 
4.4 Open field activity 
 Appendix B shows the pattern of activity in the open field on each test day.  Data 
analysis from the open field is presented in Figure 4.3.  Three-factor repeated measures 
ANOVA revealed a significant effect of surgery (p<0.001, between-subject effects) and 
day (p<0.001, within-subject effects), as well as a significant surgery by day interaction 
(p<0.001, within-subjects effects).  Diet (p=0.984), interactions of diet by day (p=0.138) 
and surgery by diet by day (p=0.924) were not significant.  
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Figure 4.3 Total distance (mean ± SEM) travelled in the open field on d3, 7, 10, 30, and 
60.  Three-factor repeated measures ANOVA demonstrated a significant effect of surgery 
(p<0.001, between-subject effects) and day (p<0.001, within-subject effects), as well as a 
significant surgery by day interaction (p<0.001, within-subjects effects).  Diet (p=0.984), 
interactions of diet by day (p=0.138) and surgery by diet by day (p=0.924) were not 
significant.  Different letters indicate significant differences among groups within a day 
by two-factor ANOVA followed by LSD post-hoc tests (p<0.05).  Sample size varied 
within a group by day because of death, euthanasia or a missed test.  SCON: sham 
surgery with control diet; SCR: sham surgery with CR; ICON: ischemic surgery with 
control diet; ICR: ischemic surgery with CR.  
 
 Sham animals showed habituation on all test days. Although both ischemic groups 
showed some habituation over time, ICON animals showed a significantly higher level of 
activity (impaired habituation) as compared to SCON animals on all test days (p<0.001). 
ICR and SCR animals were significantly different on d3, d7, and d10 (p<0.001) but not 
on d30 and d60 (p>0.05).  This was partly due to an increase in total distance traveled by 
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the SCR gerbils on these days.  There was a trend for SCR activity to increase relative to 
that of the SCON group by d60 (p=0.055).  Open field activity was significantly lower in 
the ICR group as compared to ICON gerbils on d7 only (p=0.024). 
 Figure 4.4 shows the percent of the total distance spent in the outer zone of the 
open field.  Ischemic groups spent significantly more time in the outer zone than sham 
groups as indicated by three-factor repeated measures ANOVA (p<0.001, between-
subjects effects).  Percent distance spent in the outer zone was unaffected by dietary 
treatment (p=0.664, between-subject effects). There were no significant effects of day 
(p=0.159), or the interactions diet by day (p=0.309), surgery by day (p=0.177) or surgery 
by diet by day (p=0.845).  Open field data from option b are presented in Appendix C. 
4.5 Hippocampal CA1 cell counts 
 Table 4.2 shows the effects of diet and ischemia on hippocampal CA1 neuronal 
cell counts at day 60.  Gerbils exposed to global ischemia had significantly fewer 
hippocampal CA1 neurons at each level and totalled than sham gerbils, irrespective of 
diet (p<0.001).  There was no significant independent effect of diet on histological 
outcome nor was there an interaction between surgery and diet.  Five minutes of global 
ischemia resulted in a mean (± SEM) total loss of 87.1±0.9% and 89.2±1.1 % of CA1 
neurons in gerbils fed control diet and exposed to CR respectively.  Hippocampal CA1 
neuronal cell count data for option b are presented in Appendix D.  Table 4.3 shows the 
extent of hippocampal neuron loss in individual gerbils exposed to global ischemia as 
well as the extent to which neuronal damage is consistent across both sides of the 
hippocampus.  Percent CA1 neuronal loss was calculated relative to the mean neuronal 
number of the combined sham groups.  Sham groups were combined as there was no 
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effect of diet on their CA1 neuronal counts.  All animals exposed to global ischemia 
which were included in the study on the basis of hyperactivity monitoring had extensive 
neuronal loss (77-96%) on both sides of the hippocampus with no evidence of unilateral 
damage.  The pattern of neuronal damage for option b data is shown in Appendix D. 
 
 
Figure 4.4 Percent of distance travelled spent in the outer zone of the open field on d3, 7, 
10, 30, and 60.  Ischemic groups spent significantly more time in the outer zone than 
sham groups as indicated by three-factor repeated measures ANOVA (p<0.001).  Diet 
(p=0.664), day (p=0.159), interactions of diet by day (p=0.309), surgery by day (p=0.177) 
or surgery by diet by day (p=0.845) were not significant.  SCON: sham animals with 
control diet; SCR: sham animals with CR; ICON: ischemic animals with control diet; 
ICR: ischemic animals with CR. 
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Table 4.2 Caloric restriction does not alter ischemia-induced death of hippocampal CA1 
neurons at d60: Analysis by option a. 
 SCON SCR ICON* ICR* 
Level A 261.1±5.6 264.2±3.0 31.6±2.8 26.5±3.3 
Level B 260.3±5.6 269.8±4.4 33.4±2.5 27.6±2.8 
Level C 90.8±1.9 90.0±2.0 14.9±1.1 12.7±1.2 
Total 612.1±12.0 623.9±7.7 79.9±5.4 66.8±6.5 
Mean (±SEM) cell counts were taken across the anterior-posterior axis of the hippocampus 
(Level A, ~ -1.7mm relative to bregma; level B, ~-2.2mm relative to bregma; level C, ~-
2.7mm relative to bregma); SCON, n=14; SCR, n=13; ICON, n=15; ICR, n=15.  Data were 
analyzed by two-factor ANOVA.  *Ischemia independently decreased the number of 
surviving cells at all hippocampal levels (p<0.001). SCON: sham animals with control diet; 
SCR: sham animals with CR; ICON: ischemic animals with control diet; ICR: ischemic 
animals with CR.
Table 4.3 Extent and reliability of hippocampal CA1 neuron 
loss between left and right hemispheres following five min 
of global ischemia: Analysis by option a. 
Experimental Group 
 
Left hemisphere 
 
Right hemisphere
 
(gerbil #) [neuron counts (% loss)] 
ICON  (1) 52 (83) 26 (92) 
(2) 29 (91) 36 (88) 
(3) 37 (88) 34 (89) 
(4) 34 (89) 25 (92) 
(5) 37 (88) 33 (89) 
(6) 31 (90) 31 (90) 
(7) 51 (84) 56 (82) 
(8) 44 (86) 44 (86) 
(9) 34 (89) 24 (92) 
(10) 81 (74) 52 (83) 
(11) 36 (88) 35 (89) 
(12) 53 (83) 55 (82) 
(13) 42 (87) 36 (88) 
(14) 42 (87) 32 (90) 
(15) 39 (87) 38 (88) 
ICR     (1) 58 (81) 70 (77) 
(2) 12 (96) 21 (93) 
(3) 24 (92) 21 (93) 
(4) 24 (92) 26 (92) 
(5) 29 (91) 28 (91) 
(6) 23 (93) 36 (88) 
(7) 41 (87) 42 (86) 
(8) 49 (84) 37 (88) 
(9) 34 (89) 26 (92) 
(10) 30 (90) 42 (86) 
(11) 25 (92) 44 (86) 
(12) 32 (90) 24 (92) 
(13) 38 (88) 32 (90) 
Percent neuronal loss was calculated relative to mean 
neuronal number in combined sham groups (SCON and 
SCR).  ICON: ischemic animals with control diet; ICR: 
ischemic animals with CR.
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CHAPTER 5 
DISCUSSION 
This study is the first to assess whether CR provided solely after brain ischemia 
can provide a lasting decrease in brain damage.  Using BCCAO in the gerbil, I 
demonstrated that CR did not alter long-term activity in the open field test or 
hippocampal CA1 neuron cell counts, which are two commonly used and well-validated 
measures of brain damage in this model.  Exposure to brain ischemia caused a significant 
increase in the distance travelled in the open field on all test days indicative of a spatial 
learning deficit.  CR did not ameliorate this deficit on days 3, 10, 30 or 60.  Open field 
activity was significantly lower in the ICR group as compared to ICON gerbils on d7, 
which might indicate a transient protective effect.  An interesting trend toward increased 
activity in the calorically restricted sham group relative to that of the control diet fed 
sham group by d60 suggests that the open field may have limitations for chronic studies 
of CR.  There was also no protective effect of CR on hippocampal CA1 neuron death.   
In order to undertake this study, it was necessary to employ a screening method to 
identify animals with severe forebrain ischemia as it has been shown that commercially 
available gerbils now show a high incidence of posterior communicating arteries that 
increase variability of ischemic damage (Laidley et al., 2005; Seal et al., 2006).  
Hippocampal CA1 neuron cell counts at day 60 revealed that hyperactivity screening 
correctly identified severe ischemia in 100% of cases.  Animals that underwent global 
ischemia and were included in the study on the basis of hyperactivity monitoring had
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 extensive neuronal loss (77-96%) on both sides of the hippocampus with no evidence of 
unilateral damage.  This level of damage is much less variable than that of similar recent 
studies completed without a screening procedure (Bobyn et al., 2005) and more similar to 
the extent of damage seen in studies prior to the problem of changing brain vasculature in 
the gerbil (Colbourne and Corbett, 1995)  While no animals that were included in the 
study on the basis of screening were identified by histology as having incomplete damage 
(false positive results), histology was not completed on animals removed from the study 
based on screening.  Therefore, it is not possible to report on the number of false negative 
results.  The screening accuracy and the extent and consistency of damage observed in 
the ischemic animals yields confidence in the screening process, although the large 
number of unusable animals (48.5%) makes the gerbil model of global ischemia 
undesirable, especially for large scale studies.   
 It appears that 60 days of post-ischemic CR had no protective effect on CA1 
neuronal death.  As neurons can appear viable on simple histological assessment but be 
functionally abnormal (Corbett and Nurse, 1998), open field testing was also employed to 
assess hippocampal function.  Damage to the hippocampal CA1 region is associated with 
spatial learning and memory impairments, which can be accurately detected in this model 
of global ischemia by the open field test (Corbett and Nurse, 1998; Corbett et al., 1997; 
Colbourne et al., 1998a; Colbourne et al., 1998b).   
Gerbils exposed to sham surgery showed the expected decline in total activity, 
indicative of habituation, whereas ischemic animals exhibited persistently elevated 
activity, indicating learning impairment (Colbourne and Corbett, 1995; Colbourne et al., 
1998a ; Colbourne et al., 1998b).  Although habituation improved with time after global 
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ischemia, as previously reported (Corbett and Nurse, 1998; Colbourne and Corbett, 
1995), the activity of gerbils exposed to ischemia and control diet did remain 
significantly elevated over that of the matched sham group throughout the testing period.  
The functional assessment was in agreement with the histological findings in that CR did 
not ameliorate the ischemia-induced spatial learning deficit exhibited in the open field on 
days 3, 10, 30 or 60.  The significantly lower activity of the ICR group relative to that of 
ICON gerbils on day 7 may suggest a transitory protective effect of CR.  If this 
interpretation is correct, it would illustrate the importance of long-term testing in 
experimental stroke models to identify treatments that have only transient beneficial 
effects.  Many promising therapeutic interventions that appear to be neuroprotective 
when assessed at early timepoints (1-7 days) following ischemia do not provide lasting 
benefit but only postpone cell death (Corbett and Nurse, 1998).  Although the possibility 
cannot be excluded, it is thought that the additional 5% diet required in a small number of 
CR animals to address the problem of post-surgical morbidity and mortality did not 
confound the results of this study.  This interpretation is based on the fact that excluding 
these gerbils from behavioural and histological analysis yielded the same results.  The 
limitation of this conclusion, however is that this is not an exact comparison because of 
differences in statistical power between options a and b.  
 The timing of CR is likely a key explanation for the findings of this study.  
Although CR administered beginning one day following brain ischemia might have been 
too late to affect the ischemic cascade, it was predicted that this dietary treatment would 
be able to moderate ongoing secondary processes such as inflammation and apoptosis.  
The capacity of CR to increase stress resistance pathways (de Cabo et al., 2003; Heydari 
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et al., 1996) prior to the ischemic cascade may have been essential for CR to exert 
neuroprotection, and this mechanism was precluded by the study design.  Such 
mechanisms are reminiscent of those described for ischemic preconditioning 
(Obrenovitch, 2008).  Chronic CR has previously been shown capable of inducing heat 
shock protein-70 in the striatum (Yu and Mattson, 1999).   
While post-ischemic CR may be too late to influence early events accounting for CA1 
neuronal death, 30% CR was continued up until day 60, providing ample opportunity to 
improve functional recovery by enhancing neuroplasticity mechanisms.  Considerable 
functional recovery can take place in both animal models of ischemia and in human 
stroke patients (Corbett and Nurse, 1998; Lee and van Donkelaar, 1995).  Despite this, no 
long-term benefit from CR was observed in open field performance.  No direct 
measurements of neural plasticity mechanisms were investigated, which would have 
aided interpretation of the behavioural data.   
The increased distance travelled by CR sham animals on day 60, relative to sham 
animals fed control diet, raises the possibility that interpretation of open field results have 
been confounded by the presence of CR.  The open field test has been used extensively in 
the gerbil model of global ischemia because of its sensitivity to detect differences in CA1 
injury and identify beneficial treatments (Corbett et al., 1997; Colbourne and Corbett, 
1994; Colbourne and Corbett, 1995; Colbourne et al., 1998b).  Increased open field 
activity in this model of global ischemia generally reflects decreased habituation (Wang 
and Corbett, 1990; Babcock et al., 1993).  However, this does not exclude the possibility 
of other influences on the test (Plamondon and Khan, 2005).   
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It is possible that hunger from chronic CR interfered with interpretation by increasing 
motivation to forage.  However, the post-ischemic pattern of open field activity in both 
control and CR gerbils is very similar to that previously reported in other long-term 
studies with this global ischemia model (Farrell et al., 2001; Corbett et al., 1997; 
Colbourne and Corbett, 1995), suggesting that the open field test results are valid even in 
the presence of CR.  Ideally, multiple behavioural tests should be used for more accurate 
assessment of memory deficits.  While the T-maze and radial arm maze are very sensitive 
for detecting impaired reference memory and working memory following global ischemia 
in the gerbil (Corbett and Nurse, 1998; Mileson and Schwartz, 1991; Colbourne and 
Corbett, 1995), these tests require the use of food rewards and might also be confounded 
by increased motivation in chronically hungry animals.  Future research on CR may 
benefit from the use of behavioural tests that do not require the use of food rewards such 
as the Morris water maze (Corbett and Nurse, 1998; Langdon et al., 2008), object 
recognition testing (Plamondon et al., 2008; Plamondon et al., 2006; Yukie et al., 2006) 
and operant conditioning (Spencer et al., 2008; Jing et al., 2008; Maia et al., 2004).  The 
Morris water maze has been shown to detect impairments in reference memory and 
working memory following global ischemia, but is not suitable for the gerbil, a desert 
species unsuited to swimming (Corbett and Nurse, 1998; Langdon et al., 2008).  The 
latter two other possibilities show promise in global ischemia studies although they have 
not been as well-characterized.   
 While total activity measured as distance travelled is the most commonly used 
validated endpoint for the open field test in global ischemia studies (Corbett and Nurse, 
1998), it is also possible to examine time spent in the periphery of the open field versus 
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the centre.  This is an endpoint more commonly used for assessing anxiety (Palanza, 
2001; Prut and Belzung, 2003).  Ischemic groups spent significantly more time in the 
periphery of the open field than sham groups, which could indicate increased anxiety 
(Calabrese, 2008).  Percent distance spent in the outer zone was not affected by dietary 
treatment.  Analyzing zone data for the open field did not appear to provide any 
additional information than the standard measure of activity in this study.  In fact, more 
subtle changes were detected analyzing distance travelled in the entire open field, such as 
the difference between SCON and SCR gerbils on day 60, which was not apparent from 
examining travel in the periphery. 
Another limitation of this study was the unexpected underfeeding during the first 3 
days following ischemia (40-74% energy restriction) that resulted from extrapolating 
food intake data obtained previously from group-housed gerbils to the current study with 
singly-housed gerbils.  Imposing 40-74% CR at the same time as the neuroendocrine and 
cytokine-mediated stress response to surgery (Lowry and Perez, 2005) may have been a 
factor in the morbidity and mortality observed in a small proportion of calorically 
restricted gerbils.  This severe underfeeding would have occurred in parallel with the 
elevations in resting metabolic rate, energy requirement, gluconeogenesis, and lean body 
mass breakdown that typically occur as part of the classic metabolic response to surgery 
(Lowry and Perez, 2005).  No adverse effects were reported in a recent study of energy 
restriction administered immediately following surgical induction of spinal cord injury in 
the rat (Plunet et al., 2008).  These investigators employed an IF regimen, an alternate 
form of CR in which animals are fasted and fed ad libitum on alternating days.  As this 
form of energy restriction causes less weight loss than the 30-40% CR regimens (Anson 
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et al., 2003; Goodrick et al., 1983), it may be a better way to study CR in the surgical 
models needed to invoke brain ischemia.   
 In contrast to our results with post-ischemic CR, previous studies indicate that CR 
started prior to brain ischemia might be beneficial (Yu and Mattson, 1999; Roberge et al., 
2008a; Roberge et al., 2008b).  The decrease in infarct volume induced by CR after focal 
ischemia has not yet been shown to extend beyond 24 hours (Yu and Mattson, 1999).  
This timepoint is too early following ischemia to know whether the treatment is truly 
neuroprotective or is only postponing cell death (Corbett and Nurse, 1998).  However, 
two studies in which 40% CR was provided for 30 days before and either 30 (Roberge et 
al., 2008a) or 70 days (Roberge et al., 2008b) after global ischemia demonstrated 
improvements in working memory in the radial arm maze.  Although the potential 
confounding influence of hunger was acknowledged, the comparable performance 
between CR and control-fed sham rats suggests that the radial arm maze results are valid 
(Roberge et al., 2008a; Roberge et al., 2008b).  The mechanisms responsible for the 
improved recovery remain to be identified.  Although CR may have exerted beneficial 
effects both before and after ischemia in these studies, the interpretation is somewhat 
confounded as CR was postponed for five days after ischemia.  Presumably the latter was 
done to avoid complications with the combination of CR and surgical stress, such as was 
encountered in the present study.  Although potential effects of CR on intra- and/or post-
ischemic brain temperature were not ruled out in these studies (Roberge et al., 2008a; 
Roberge et al., 2008b), any hypothermia that may have occurred was not of sufficient 
magnitude to reduce hippocampal neuron death.  While intra-ischemic brain temperature 
was strictly controlled in our study, post-ischemic brain temperature was not and is a 
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limitation of this study as well.  The finding that CR did not affect neuron survival 
suggests that the CR-induced reduction in memory deficit was caused by enhanced 
function of either the remaining hippocampal neurons or those in other brain regions. 
Further studies linking functional outcome with cell death and neural plasticity 
mechanisms with different paradigms and timing of CR will be insightful for 
understanding neuronal death and recovery processes following brain ischemia.  For 
example, although there are few studies in which CR and IF have been directly 
compared, some data indicate that results may vary with the caloric restriction paradigm; 
it has been suggested that cellular stress resistance pathways may be activated to different 
degrees (Mattson and Wan, 2005).  Whether or not CR can permanently decrease 
neuronal death after brain ischemia, there is increasing evidence that CR can positively 
influence hippocampal plasticity (Stranahan and Mattson, 2008; Gillette-Guyonnet and 
Vellas, 2008), which suggests that the study of these mechanisms after brain ischemia is 
warranted.   
 In conclusion, 30% CR provided after global ischemia does not improve long-
term functional outcome in the open field test or hippocampal CA1 neuronal 
degeneration.  Thus, within the confines of this CR paradigm, CR did not prove to be an 
effective means of improving outcome following global ischemia.  Evidence from other 
studies of functional improvement with combined pre- and post-ischemic CR, however, 
suggests that it remains a valuable tool to elucidate mechanisms by which the brain 
protects itself against ischemic injury.  Future research should examine other paradigms 
of CR.  Few studies have directly compared CR and IF (Anson et al., 2003).  While both 
paradigms produce similar results, they may act through different mechanisms.  
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Intermittent fasting may be a better way to study CR in models of brain ischemia as it 
results in less dramatic weight loss than controlled CR, possibly reducing the risk for 
morbidity and mortality.  It is also important that future studies attempt to employ 
multiple behavioural tests.  The use of multiple behavioural tests can provide a more 
accurate assessment of functional deficits following stroke and the effects of potential 
therapeutic treatments.  It may be especially valuable to characterize functional tests that 
do not require the use of food rewards as it is possible that these rewards may confound 
nutritional studies.  Due to the considerable functional recovery that can occur following 
stroke it would also be beneficial to examine The effects of CR on neuroplasticity 
mechanisms such as synaptic reorganization (e.g. dendritic morphology) or neurogenesis.  
A better understanding of the effects and mechanisms of CR could lead to new 
approaches for improving brain damage following stroke including the development of 
CR mimetics.   
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APPENDIX A 
 
Figure A.1 Mean (±SEM) body weight throughout the post-surgical period: Analysis by 
option b.  Initial body weight on the day of surgery (shown as d0) was not significantly 
different among groups, but from d7 onwards, CR gerbils weighed significantly less than 
gerbils on the CON diet (p<0.001), as determined by two-factor ANOVA and LSD post 
hoc tests.  SCON: sham surgery with control diet; SCR: sham surgery with CR; ICON: 
ischemic surgery with control diet; ICR: ischemic surgery with CR.  
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APPENDIX B 
Figure B.1 
 
Figure B.2 
 
81 
 
Figure B.3 
 
Figure B.4 
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Figure B.5 
 
Figure B Pattern of habituation in the open field by the four experimental groups (option 
a).  Figures B1-B5 show mean (±SEM) total distance travelled on d 3, 7, 10, 30, and 60, 
respectively.  SCON: sham surgery with control diet; SCR: sham surgery with CR; 
ICON: ischemic surgery with control diet; ICR: ischemic surgery with CR. 
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APPENDIX C 
 
Figure C.1 Total distance (mean ± SEM) travelled in the open field on d3, 7, 10, 30, and 
60: Analysis by option b.  Three-factor repeated measures ANOVA demonstrated a 
significant effect of surgery (p<0.001, between-subject effects) and day (p<0.001, within-
subject effects), as well as a significant surgery by day interaction (p<0.001, within-
subjects effects).  Diet (p=0.767), interactions of diet by day (p=0.209) and surgery by 
diet by day (p=0.477) were not significant.  Different letters indicate significant 
differences among groups within a day by two-factor ANOVA followed by LSD post-hoc 
tests (p<0.05).  Sample size varied within a group by day because of missed tests. SCON: 
sham surgery with control diet; SCR: sham surgery with CR; ICON: ischemic surgery 
with control diet; ICR: ischemic surgery with CR. 
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 Figure C.2 Percent of distance travelled spent in the outer zone of the open field on d3, 7, 
10, 30, and 60: Analysis by option b.  Ischemic groups spent significantly more time in 
the outer zone than sham groups as indicated by three-factor repeated measures ANOVA 
(p<0.001).  Diet (p=0.839), day (p=0.230), interactions of diet by day (p=0.489), surgery 
by day (p=0.471) or surgery by diet by day (p=0.777) were not significant.  SCON: sham 
animals with control diet; SCR: sham animals with CR; ICON: ischemic animals with 
control diet; ICR: ischemic animals with CR.  
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APPENDIX D 
Table D.1 Caloric restriction does not alter ischemia-induced death of hippocampal CA1 
neurons at d60: Analysis by option b 
 SCON SCR ICON* ICR* 
Level A 261.1±5.6 263.3±3.0 31.6±2.8 27.0±4.2 
Level B 260.3±5.6 267.1±5.2 33.4±2.5 29.0±3.5 
Level C 90.8±1.9 89.7±2.7 14.9±1.1 13.6±1.4 
Total 612.1±12.0 620.1±8.9 79.9±5.4 69.6±8.4 
Mean (±SEM) cell counts were taken across the anterior-posterior axis of the 
hippocampus (Level A, ~ -1.7mm relative to bregma; level B, ~-2.2mm relative to 
bregma; level C, ~-2.7mm relative to bregma); SCON, n=14; SCR, n=10; ICON, n=15; 
ICR, n=10.  Data were analyzed by two-factor ANOVA.  *Ischemia independently 
decreased the number of surviving cells at all hippocampal levels (p<0.001). SCON: 
sham animals with control diet; SCR: sham animals with CR; ICON: ischemic animals 
with control diet; ICR: ischemic animals with CR.   
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Table D.2 Extent and reliability of hippocampal CA1 
neuron loss between left and right hemispheres following 
five min of global ischemia: Analysis by option b. 
Experimental Group 
 
Left hemisphere 
 
Right hemisphere
 
(gerbil #) [neuron counts (% loss)] 
ICON  (1) 52 (83) 26 (91) 
(2) 29 (91) 36 (88) 
(3) 37 (88) 34 (89) 
(4) 34 (89) 25 (92) 
(5) 37 (88) 33 (89) 
(6) 31 (90) 31 (90) 
(7) 51 (84) 56 (82) 
(8) 44 (86) 44 (86) 
(9) 34 (89) 24 (92) 
(10) 81 (74) 52 (83) 
(11) 36 (88) 35 (89) 
(12) 53 (83) 55 (82) 
(13) 42 (87) 36 (88) 
(14) 42 (87) 32 (90) 
(15) 39 (87) 38 (88) 
ICR     (1) 58 (81) 70(77) 
(2) 12 (96) 21 (93) 
(3) 24 (92) 21 (93) 
(4) 24 (92) 26 (91) 
(5) 41 (87) 42 (86) 
(6) 49 (84) 37 (88) 
(7) 34 (89) 26 (91) 
(8) 30 (90) 42 (86) 
(9) 25 (92) 44 (86) 
(10) 38 (88) 32 (89) 
Percent neuronal loss was calculated relative to mean 
neuronal number in combined sham groups (SCON and 
SCR).  
 
